hat
Rezilta: Semb te rapòte pa 36.7 (n = 205) nan echantiyon an. Pifò itilizatè SEMB (78) te gason. Apre ajisteman pou démographie, itilizatè SEMB, konpare ak nonusers, rapòte pi gwo sentòm depresyon, pi pòv kalite lavi, plis mantal- ak fizik-sante jou diminye, ak pi ba estati sante.
eng
RESULTS: SEMB was reported by 36.7% (n = 205) of the sample. Most SEMB users (78%) were men. After adjusting for demographics, SEMB users, compared to nonusers, reported greater depressive symptoms, poorer quality of life, more mental- and physical-health diminished days, and lower health status.